跳至主要内容
临床试验/PER-002-05
PER-002-05已完成1 期

ELIMINATION OF CYSTICERCOSIS IN PER

BILL & MELINDA GATES FOUNDATION,0 个研究点目标入组 103,554 人开始时间: 2005年2月7日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
103,554

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 0(—)

入选标准

  • - Resident of the rural areas of Tumbes, Talara and Sullana (who stays at least two nights in the
  • - Resident over two years.

排除标准

  • - Residents who refuse to participate in the study.
  • - Women in gestation will not receive massive treatment of niclosamide.
  • - Participants with a history of adverse effects to nidosamide will not participate in the mass treatment.

研究者

相似试验